I come across bios everyday. Each unique , different . But I see some of these trading at .1. .2 .3 with bigger os and half the drug opportunity , this is possible billion dollar heart drug in phase 3.

It’s really nothing. We just wait for updates. Probably 20 plus people holding off adding until next updates. Filings and updates. Then those ask get pummeled

I’m pretty surprised at how he’s acted. He could flush at times create more action. But he’s in absolutely no rush and not much desire to let them go to cheap.

I think it’s possible . Wow. This is thin

I thinks a wild card. once current with filings and press releases: anything possible, if masses catch wind could run 500% plus. Or could churn awhile. Open to it all.

Amazing company! I
Think this crxm partnership news is very solid and. Look
At news prs Fuji
All mega projects

https://fujifilmdiosynth.com/about-us/news/

I think they continue to drizzle out. Because they are small “preferred” share conversion batches they don’t trigger any reporting requirements. If crxm can deliver fins and updates we could trade much higher valuation. This market is booming and could set stage for future funding / deals . Got to capitalize! I think sabby is 95% done. Just a guess watching l2 past month. Appreciate your blog! One of best write upd I’ve seen in awhile otc.

$150M revenue producing cryptocurrency exchange and custody services platform: CGCX Ltd.

Looking great! Let’s go crxm bring the updates. Anyday now more filings imo

I have added a good amount and upon proper filings / updates I will add even more. Come on crxm let’s go

I think it’s coming very soon. I think we are inches from sabby gone. Now just Get current and drop some nice updates. Is better scenario to have him gone in .05s.

Wow!! gmg* trades at 300m cap and is same ceo as Elra, We could have serious gaming play here. Been watching Elra long time. Great start

https://mobile.twitter.com/dx_helios/status/1389961041606496261

I just keep adding. 05. 50m os . Phase 3. Updated filings. Multi Billion dollar heart drug. At any moment major news could drop and it’s going to mega breakout.

Website is just pulling from a quote system. Using the most recent data available. Os going to be a hair higher. I seen you post this article below, I recommend all read this blog. We could seriously be looking at buyout or major partnership on this. This is big business! Billions in yearly sales for 1-2 drugs and Generx is unique fast track drug.

https://seekingalpha.com/instablog/22758161-altitrade-partners/5571234-potential-billion-dollar-heart-drug-catapult-shares-of-gene-biotherapeutics-much-higher

I read it. Very professional presentation. They are coming to play ball. I think major updates, partnership could be announced very soon. 1-2 catalyst away from big a breakout.

Phase 3. Multi Billion dollar heart drug. OS 50m To 65 million

Plus you have at least one form 4 showing a 4mil holder. Multiple other million share holders from what I’ve heard posted. Even if os is 65mil will prob only be half that avail with so many long,
When this stock gets its mojo there till be zero time to size below .1. So people can wait but when u least expect it. A spark will send it.

Big league . This a gem .

And if you slap ask with muscle there is nothing there .

He could just get over it. But, is in a semi no hurry type mode. It’s unique dilution lol

Agree. It’s just enough to hold us up though. End could be real close

Oh my. I did not see that yet. Nice catch.

I forgot I owned a small amount this. Seen pop in my account and went to sell and I’m
Like what is this ticker. Looked into dd and started buying vs selling, lol. I see what some longs see now. One Interesting play here. Unique. Hope it hits big for everyone.

But, I will say this about the 50M OS and Float . There is handful a longs from my reading. Who beleive this is multi dollar stock and as such probably half of that 50M is in strong hands

I feel really weird saying "unfortuantely" the foat is near the whole 50M, In the context of a multi billion dollar phase 3 with 50m os and float at .05 is "ok" I beleive float and OS are both near 50M

Thanks, I had to get to bottom of this. too much potential here, but was clear we had controlled selling reccently.

Nostrum imo has converted none. They are holding the 220. So we have to deal with the 570 series A. Its saying they converted 397 of the 570. That leaves around 173 left. They convert at 88,496 x 173 remaining is 15.3 million more


Series A Convertible Preferred Stock from Sabby, which is convertible into 88,496 shares of common stock. Consequently, the 220 shares are convertible into an aggregate of 19,469,026 shares of Common Stock. Nostrum also agreed to purchase up to 570 additional Series A Convertible Preferred Stock from Sabby, within one year following the effective date of the transaction. Since May 2020, 397 shares of Series A Preferred Stock have been converted into 35,132,755 shares of our Common Stock (conversion rate of 88,496), that has increased our outstanding Common Stock to 49,622,154 shares as of March 31, 2021. As a result of these transactions, Nostrum currently controls approximately 75.2% of the voting interests of our Company.

All Converted Nostrum would own about 170M os, but they have converted none. ANd this Fully diluted OS is what they are now saying 75% voting would be based off

May 2020, after the period covered by this report, we entered into a Preferred Stock Purchase Agreement with Nostrum Pharmaceuticals, LLC (“Nostrum”), selling Nostrum 1,700,000 shares of our newly authorized Series B Convertible Preferred Stock in exchange for $1,700,000. Each share of Series B Convertible Preferred Stock is convertible into shares of Common Stock at a conversion ratio of 0.0113. Consequently the 1,700,000 shares are convertible into an aggregate of 150,442,478 shares of Common Stock. In addition, Nostrum entered into an agreement with Sabby Healthcare Master Fund Ltd. (“Sabby”), the sole holder of our outstanding Series A Convertible Preferred Stock, under which Nostrum purchased 220 shares of our Series A Convertible Preferred Stock from Sabby, which is convertible into 88,496 shares of common stock. Consequently, the 220 shares are convertible into an aggregate of 19,469,026 shares of Common Stock.

Thats right, they used to own near 90%. after series B deal. But now since sabby diluted once they convert there series A and B they will be at 75% imo

The 220 "They Purchased". the 570 only agreed to purchase up to but Sabby still had right sell , imo

In May 2020, after the period covered by this report, we entered into a Preferred Stock Purchase Agreement with Nostrum Pharmaceuticals, LLC (“Nostrum”), selling Nostrum 1,700,000 shares of our newly authorized Series B Convertible Preferred Stock in exchange for $1,700,000. Each share of Series B Convertible Preferred Stock is convertible into shares of Common Stock at a conversion ratio of 0.0113. Consequently the 1,700,000 shares are convertible into an aggregate of 150,442,478 shares of Common Stock. In addition, Nostrum entered into an agreement with Sabby Healthcare Master Fund Ltd. (“Sabby”), the sole holder of our outstanding Series A Convertible Preferred Stock, under which Nostrum purchased 220 shares of our Series A Convertible Preferred Stock from Sabby, which is convertible into 88,496 shares of common stock. Consequently, the 220 shares are convertible into an aggregate of 19,469,026 shares of Common Stock. Nostrum also agreed to purchase up to 570 additional Series A Convertible Preferred Stock from Sabby, within one year following the effective date of the transaction. Since May 2020, 397 shares of Series A Preferred Stock have been converted into 35,132,755 shares of our Common Stock (conversion rate of 88,496), that has increased our outstanding Common Stock to 49,622,154 shares as of March 31, 2021. As a result of these transactions, Nostrum currently controls approximately 75.2% of the voting interests of our Company.

Read carefully. Nostrum wanted to also buy 570 series A from Sabby. But sabby been converting instead. Why os went up 35m plus 15m. 50m os. Nostrum has not converted any series a or b. This means sabby only has 170 series A left or around 15m. 10k showed os from March 31st I believe. So we could already be through a nice chunk of that. Explains the selling. But very controlled selling.

In addition, Nostrum entered into an agreement with the holder of our outstanding Series A Convertible Preferred Stock, under which Nostrum purchased 220 shares of our Series A Convertible Preferred Stock, convertible into an aggregate of 19,469,026 shares of Common Stock and agreed to purchase up to 570 additional Series A Convertible Preferred Stock. Since May 2020, such holder has converted 397 shares of Series A Convertible Preferred Stock into 35,132,755 shares of our Common stock, that has increased our outstanding Common Stock to 49,622,154 shares as of March 31, 2021

In May 2020, after the period covered by this report, we entered into a Preferred Stock Purchase Agreement with Nostrum Pharmaceuticals, LLC (“Nostrum”), selling Nostrum 1,700,000 shares of our newly authorized Series B Convertible Preferred Stock in exchange for $1,700,000. Each share of Series B Convertible Preferred Stock is convertible into shares of Common Stock at a conversion ratio of 0.0113. Consequently the 1,700,000 shares are convertible into an aggregate of 150,442,478 shares of Common Stock. In addition, Nostrum entered into an agreement with Sabby Healthcare Master Fund Ltd. (“Sabby”), the sole holder of our outstanding Series A Convertible Preferred Stock, under which Nostrum purchased 220 shares of our Series A Convertible Preferred Stock from Sabby, which is convertible into 88,496 shares of common stock. Consequently, the 220 shares are convertible into an aggregate of 19,469,026 shares of Common Stock. Nostrum also agreed to purchase up to 570 additional Series A Convertible Preferred Stock from Sabby, within one year following the effective date of the transaction. Since May 2020, 397 shares of Series A Preferred Stock have been converted into 35,132,755 shares of our Common Stock (conversion rate of 88,496), that has increased our outstanding Common Stock to 49,622,154 shares as of March 31, 2021. As a result of these transactions, Nostrum currently controls approximately 75.2% of the voting interests of our Company.

Wow . Phase 3 at .05. 50m os

The company would also like to mention that we are bringing the entire set of Hydrogen Companies into Good Standing. This process has begun and our 100% owned Novofuel, Inc. is now in Good Standing.

https://www.otcmarkets.com/stock/AFPW/news/story?e&id=1802795

NovoFuel's Advanced High Capacity Lithium-Ion Batteries Ready For Nationwide Markets

https://www.accesswire.com/439194/NovoFuels-Advanced-High-Capacity-Lithium-Ion-Batteries-Ready-For-Nationwide-Markets

older news above, But its clear from PR today they are ready to roll with Novafuel now. EV Battery Play

All company has to do is talk about its smart energy and .01. Will they?

The smart energy play here is enormous with Biden dedicating billions to this sector.

In 2009, Mr. Szoradi was elected to the Board of the Sustainable Business Network and selected as a member of the Green Economy Task Force, with direct participation on the Capitol Hill Delegation

Full bio.
https://independenceled.com/bios/


Corporate Summary. Massive govt jobs
https://independenceled.com/pdfs/Independence-LED-Lighting-Sample-U.S.-Public-and-Private-Sector-Solutions-Q1-2020.pdf

Nee tweet. PR COMING

FOMO'S PURGE VIRUS NOW LIVE ON ALIBABA - PR PENDING

— FOMO WORLDWIDE, INC. (@FOMO_CORP) January 12, 2021

Micro Grid Tech Benefits incluse EV CHARGE

https://independenceled.com/dc-microgrids/


Independence LED Lighting developed its first Direct Current (DC) powered LED fixture series in 2015 for an industrial facility. Our DC LED fixtures are “driverless” with 24 volt DC wiring from a “Power hub Driver” (PhD), which is provided by our strategic partner Nextek Power Systems. Together, we are at the forefront of DC Microgrids, with the proven systems that leverage high efficiency power converters and smart controls to optimize energy usage while drawing power from renewables, batteries, and/or the grid.

In the past this could be relevant. But in today’s market it’s no excuse. Hbr*. Os is the float and it’s bigger then apyp. So all I care about on apyp is OS. Which is 5.4b if the float is 5.4b so be it. Now it’s just a matter of Will apyp bring the heat!

Obviously this is the one increase to consider . But as you noted was 12/1. So it’s been over 30 days and 100s millions in volume. I’m assuming that was devoured. So far os unchanged again today. https://www.otcmarkets.com/stock/APYP/profile